Screening assay based on nine lipids commonly dysregulated in early-stage lung cancer
Promoting low-dose CT screening among mostly nonsmoking women increased detection of early-stage, but not late-stage, lung cancers
Promoting low-dose CT screening among mostly nonsmoking women increased detection of early-stage, but not late-stage, lung cancers
Blood test based on four-marker protein panel combined with risk prediction model may improve assessment of risk for lung cancer
Compared with 2013 USPSTF criteria, more patients eligible for lung cancer screening with less racial disparity in access
During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer
Diagnostic shift from later-stage to earlier-stage disease may have implications for evaluation of treatments and mortality outcomes
Predictive models based on comparison of serum metabolomic patterns for patients at time of lung cancer diagnosis and matched controls
National five-year survival rate for lung cancer has increased to 23.7 percent, but disparities persist for people of color
But majority of U.S. Black women diagnosed with lung cancer still would have been ineligible for screening under 2021 USPSTF guideline